Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kohnen

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Pharmacopsychiatry|May 20, 1999
Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studiesA Delini-Stula, D Baier, R Kohnen, et al.
Versicherungsmedizin|August 1, 1996
[ICD diagnoses in university polyclinic naturopathy consultation]C Hentschel, M Lindner, B Brinkhaus, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Clinical and biochemical findings in uremic patients with and without restless legs syndromeV Collado-Seidel, R Kohnen, W Samtleben, et al.
MMW Fortschritte Der Medizin|May 5, 2000
[Phytotherapeutic drugs for the common cold. Results of a randomized controlled double-blind study]C Hentschel, J Schnitker, R Kohnen, et al.
Sleep|October 1, 1995
New actigraphic assessment method for periodic leg movements (PLM)J Kazenwadel, T Pollmächer, C Trenkwalder, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2008
Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trialM Hornyak, C Grossmann, R Kohnen, et al.
Der Nervenarzt|December 1, 1995
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]T E Eichhorn, A Schrag, C Trenkwalder, et al.
Clinical Nephrology|January 1, 1995
Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 monthsH H Neumayer, L Färber, P Haller, et al.
Transplantation Proceedings|October 1, 1994
Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 monthH H Neumayer, L Färber, P Haller, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Pharmacopsychiatry|May 20, 1999
Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor--results of the drug utilization observation studiesA Delini-Stula, D Baier, R Kohnen, et al.
Versicherungsmedizin|August 1, 1996
[ICD diagnoses in university polyclinic naturopathy consultation]C Hentschel, M Lindner, B Brinkhaus, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 20, 1998
Clinical and biochemical findings in uremic patients with and without restless legs syndromeV Collado-Seidel, R Kohnen, W Samtleben, et al.
MMW Fortschritte Der Medizin|May 5, 2000
[Phytotherapeutic drugs for the common cold. Results of a randomized controlled double-blind study]C Hentschel, J Schnitker, R Kohnen, et al.
Sleep|October 1, 1995
New actigraphic assessment method for periodic leg movements (PLM)J Kazenwadel, T Pollmächer, C Trenkwalder, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 28, 2008
Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trialM Hornyak, C Grossmann, R Kohnen, et al.
Der Nervenarzt|December 1, 1995
[Effectiveness of slow release L-DOPA/benserazide in treatment of end-of-dose akinesia in Parkinson disease]T E Eichhorn, A Schrag, C Trenkwalder, et al.
Clinical Nephrology|January 1, 1995
Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 monthsH H Neumayer, L Färber, P Haller, et al.
Transplantation Proceedings|October 1, 1994
Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 monthH H Neumayer, L Färber, P Haller, et al.
Pageof 8